The replication of simian virus 40 (SV40) origin-containing DNA has been reconstituted by using SV40 large tumor (T) antigen and cellular proteins purified from HeLa cells. This replication reaction is unaffected by proliferating-cell nuclear antigen (PCNA). In contrast, PCNA has been reported to stimulate SV40 DNA synthesis carried out with crude fractions [Prelich, G., Kostura, M., Marshak, D. R., Nature (London) 326, [471][472][473][474][475]. This difference is caused by the presence of a protein in crude fractions that inhibits the elongation of nascent DNA chains during replication. In the presence of PCNA, crude fractions containing this elongation inhibition factor can extend DNA chains. We describe the partial purification of this inhibitor and show that its addition limited SV40 DNA replication to the synthesis of short chains, an effect reversed by the addition of PCNA. However, the reversal of the inhibition by PCNA in the SV40 system required additional protein fractions distinct from PCNA and the enzymes constituting the purified system. These results suggest that the PCNA-mediated effect on SV40 DNA replication may be indirect. Such an interplay between negative and positive regulatory functions including PCNA may contribute to the control of DNA synthesis characteristic of the eukaryotic cell cycle.
acteristic of the eukaryotic cell cycle.
The replication of DNA containing the simian virus 40 (SV40) origin of replication can be carried out in vitro (1) (2) (3) . Investigation of the proteins involved in this process has revealed required roles for DNA polymerase a and DNA primase (4) , topoisomerases I and II (5) , and a single-stranded-DNAbinding protein (SSB) purified from human cells (6) (7) (8) . We have reported the reconstitution of a SV40 DNA replication system utilizing purified SV40 large tumor (T) antigen, HeLa SSB, topoisomerase I or II, and DNA polymerase a-primase complex (6) , which supports both leading-and lagging-strand synthesis (9) . Furthermore, closed circular duplex DNA products were formed when these proteins were supplemented with purified RNase H and a 5' -) 3' exonuclease, which combine to remove RNA primers, and DNA ligase (9) . In contrast, replication of SV40 origin-containing (ori+) DNA was recently shown to require an additional protein, proliferating-cell nuclear antigen (PCNA), when the reaction was carried out with partially purified fractions. PCNA was required for the synthesis of the leading DNA strand, and in its absence only low molecular weight DNA products (150 nucleotides long) accumulated (10, 11) .
PCNA was identified previously as a protein that interacts with the sera of some patients with systemic lupus erythematosus (12, 13) . It is detected in the nuclei of proliferating cells but not of quiescent cells, and it is identical to cyclin (14) , a protein synthesized preferentially during the S phase of the cell cycle (15) (16) (17) (18) . In addition, PCNA was demonstrated by immunofluorescence to reside only in the cell nucleus and to increase during S phase (17, 19, 20) . However, PCNA is quite stable in the cell, and its level remains fairly constant throughout the cell cycle (17, 21, 22) . The location of PCNA in the nucleus during S phase, shown by immunofluorescence, corresponds to the sites of DNA synthesis (17, (19) (20) (21) . These results led to the suggestion that PCNA plays some role in DNA replication (17, 20) . This suggestion was further supported when a protein isolated as an accessory factor for DNA polymerase 8 (23) was shown to be identical to PCNA (18, 24, 25) , and with the demonstration of a role for PCNA in SV40 DNA replication (10, 11, 25 ).
Here we show that the synthesis of SV40 DNA with purified proteins is unaffected by PCNA or by antibodies against PCNA. To reconcile these findings with the observations described above, we investigated the nature of the PCNA effect in crude fractions of HeLa cell extracts. We detected a protein that inhibits the elongation phase of SV40 DNA replication. In addition, this inhibition factor blocks a number of reactions that occur at DNA ends, such as the action of DNA ligase and both 5' -* 3' and 3' --5' exonucleases. The inhibition of SV40 replication can be overcome by the addition of PCNA plus other protein fractions, which in the absence of the elongation inhibitor have no effect on the in vitro replication of SV40 DNA. These results suggest that the stimulation of SV40 DNA replication by PCNA is indirect, manifesting itself only in the presence of the inhibitor. (1.4 x 105units/mg), and DNA ligase (0.8 unit/mg) were prepared as described (9) . PCNA (5.2 x 105 units/mg) was purified to near homogeneity by a modification of the procedure of Prelich et al. (11, 25) ; a linear gradient of NaCl (0.175-0.6 M) was used in the DEAEcellulose step, and hydroxylapatite (Bio-Rad) was substituted for the Q-Sepharose column. The source of the antibodies against PCNA was a human lupus serum (AK), which was generously supplied by Eng M. Tan. This serum was shown by Tan and coworkers to be relatively monospecific for PCNA (13, 26) and it inhibited the ability of PCNA to act as a DNA polymerase 8 auxiliary protein (24) .
MATERIALS AND METHODS
Assay and Fractionation of the Elongation Inhibitor. The inhibitor was measured by the SV40 replication assay.
Abbreviations: SV40, simian virus 40; SV40 T antigen, SV40-encoded large tumor antigen; SSB, single-stranded-DNA-binding protein; PC, phosphocellulose; dsDNA, double-stranded DNA; PCNA, proliferating-cell nuclear antigen.
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Proc. Natl. Acad. Sci The starting material for the isolation of the inhibitor was the 1 M NaCl PC fraction (fraction II) described by Prelich et al. (11) , prepared from HeLa extract. This fraction (476 mg) was rechromatographed on a PC column (5 mg of protein per ml of bed volume; 2.5 x 20 cm) equilibrated with buffer A [25 mM Tris HCl, pH 7.5/10% (vol/vol) glycerol/1 mM dithiothreitol/1 mM EDTA/0.01% Nonidet P-40/0.1 mM phenylmethylsulfonyl fluoride] containing 25 mM NaCl and was eluted stepwise with buffer A (180 ml per step) containing 0.3, 0.4, 0.6, and 0.8 M NaCl. All fractions were dialyzed against buffer A containing 20% (wt/vol) sucrose and 25 mM NaCl. The 0.6 M PC fraction, containing the inhibitor (119 mg; 33,000 units), was adjusted to 0.2 M NaCl, applied to a double-stranded-DNA (dsDNA)-cellulose column (8.0 mg of protein per ml of bed volume; 2.5 x 3.0 cm) equilibrated with buffer A containing 25 mM NaCl, and eluted stepwise with the same buffer (40 ml per step) containing 0.2, 0.4, 0.6, and 0.8 M NaCl. The inhibitory activity was eluted at 0.6 M NaCl and was dialyzed against buffer A containing 25 mM NaCl. This fraction (1.17 mg of protein, 4912 units) was concentrated by adsorption to a 0.8-ml dsDNA-cellulose column and eluted with 1.0 M NaCl in buffer A. This concentrated dsDNA-cellulose fraction (0.91 mg of protein, 2800 units) was dialyzed against buffer A containing 25 mM NaCl. An aliquot (0.2 ml, 0.13 mg of protein, 400. units) of the concentrated dsDNA-cellulose fraction was adjusted to 0.25 M NaCl and layered onto a 5.0-ml linear gradient of glycerol (15-35%, vol/vol) in buffer A containing 0;25 M NaCl. Gradients were centrifuged at 45,000 x g for 24 hr in a Sorvall AH650 rotor at 4°C. Thirty fractions (0.17 nl1) were collected from the bottom, and bovine serum albumin (Miles) was added to each fraction (0.2 mg/ml) immediately after collection in order to stabilize the activity. The inhibitor peaked at fraction 18 (from the bottom), which corresponded to a sedimentation coefficient of 4.2 S. The pool of fractions 16-20 yielded 60% of the activity applied to the gradiept. The overallpurification of the inhibitor was at least 100-fold with a yield of 5% starting from the 0.6 M PC fraction.
RESULTS
PCNA Is Not Required for Replication of SV40 DNA with Purified Proteins. SV40 T antigen, HeLa SSB, HeLa DNA polymerase a-primase complex, and topoisomerase I supported SV40 DNA replication in vitro (6, 9) , and this reaction was unaffected by the addition of PCNA ( Reaction mixtures were supplemented with various amounts of PCNA and incubated at 370C for 90 min. DNA synthesis in the absence of PCNA was defined as 100% and was equal to 44 pmol of dTMP incorporated into acid-insoluble material. (B) The protein components of the replication reaction were incubated at 0C for 30 min in the presence of various amounts of anti-PCNA serum; the remaining components then were added and the mixtures were incubated at 37TC for 90 min. PCNA. However, the possibility that PCNA levels below this amount could have supported the replication reaction was examined. A human lupus serum monospecific for PCNA was previously shown to neutralize PCNA activity (24) . This anti-PCNA serum had no effect on SV40 DNA replication with purified proteins (Fig. 1B) . When topoisomerase II, RNase H, the 5' --3' exonuclease, and DNA ligase were included in the above reaction mixture, both leading-and lagging-strand synthesis and the production of covalently closed monomer circles occurred (9) . The amount and the nature of the DNA products formed by this replication system were unaffected by the addition of PCNA or anti-PCNA serum (data not shown). These experiments indicated that the purified replication system was not contaminated with PCNA and did not require PCNA.
PCNA Is Required for Efficient Replication of SV40 DNA in Crude Extracts. In contrast to SV40 DNA replication with purified proteins, replication with crude fractions has been shown to be stimulated by PCNA (10, 25) . Consistent with this observation, anti-PCNA serum inhibited SV40 DNA replication catalyzed by crude extracts of HeLa cells =90% ( Fig. 2A) . Purified PCNA restored 70% of the inhibited DNA synthesis, thus demonstrating that the inhibition by the anti-PC A serum was caused specifically by the neutralization of 1CNA in the crude extract (Fig. 2B) ase a and DNA primase activities eluted from the column, whereas the other fractions were devoid of these activities and did not support dNMP incorporation (data not presented). In contrast to the results obtained with the parental 1 M PC fraction, the 0.3 M PC fraction supplemented with SV40 T antigen, HeLa SSB, and topoisomerase I supported DNA replication, and this reaction was largely unaffected by PCNA (Fig. 3, lanes 3 and 4) . However, when the 0.3 M NaCl, polymerase-rich PC fraction was combined with the fractions eluted at higher salt concentrations, replication was inhibited and the addition of PCNA partially reversed this effect (Fig. 3, lanes 5-10) . It was evident that the PC fractions that eluted at 0.6 and 0.8 M NaCl contained the majority of the inhibitory activity. When fractions that were eluted at higher salt concentrations were added to the reaction together (Fig. 3, lanes 11-18) of replication products were observed. The addition of the 0.4 M PC fraction and PCNA (Fig. 3, lanes 6 and'12) appeared to stimulate the amount of long product formed. Most strikingly, the synthesis of long DNA products was reduced by the higher salt fractions, and it was the synthesis of the long products that was restored by PCNA. Thus, the inhibitor appears to block the elongation step of DNA synthesjs, leading to the accumulation of short DNA fragments.' hese results are in keeping with the observations describe in Figs. 1 and 2 . The replication of SV40 DNA with purnpd proteins devoid of the inhibitor was unaffected by PCi4A or antibodies against this protein, whereas cruder fractions, containing the inhibitor, required PCNA and were inhibited by neutralizing antibodies against PCNA.
Thp ability of the inhibitor to block the synthesis of SV40 DNA replication was used as an assay to further purify this activty, as described in Materials and Methods. The inhibitory 4ctivity (of either the dsDNA-cellulose or glycerol gradient fractions) was destroyed by heat and proteinase K treatment. Fractions containing the inhibitor activity also blocked a number of enzymatic reactions that occurred at DNA termini, including the action of exonuclease III, the 5' --3' exonuclease (9), and DNA ligase. The inhibition of these activities and the elongation inhibitor copurified, were heat-inactivated at the same rate, and were resistant to Nethylmaleimide. Although the inhibitory activity was Nethylmaleimide-resistant in all ofthese assays, the inhibition of DNA chain elongation by N-ethylmaleimide-treated inhibitor (dsDNA-cellulose) was not reversed upon addition of PCNA (data not shown).
Effect of the Inhibitor on the Rate of Replication and the Size of DNA Products. Reactions containing SV40 T antigen, HeLa SSB, topoisomerase I, and the 0.3 M PC fraction supported replication of SV40 DNA and accumulated products of increasing lengths at the same rate in the presence or absence of PCNA (Fig. 4) . In the presence of the inhibitor, the rate and extent of DNA synthesis were markedly reduced, as was the size of the DNA products. In contrast, when reactions contained PCNA and the inhibitor, the rate of synthesis and the size ofDNA products were almost the same as those observed in the absence of the inhibitor, though some differences in the size of products were noted at early times (5 and 10 min). These results were qualitatively similar 8 to those described by Prelich and Stillman (10) with the exception that the accumulation of small products observed in Fig. 4 was governed by the inhibitor, and not by the absence of PCNA; PCNA affected chain elongation only in the presence of the inhibitor. PCNA-Mediated Reversal of Inhibition Requires Additional Factors. When immunopurified DNA polymerase a-primase complex was used in place of the 0.3 M PC fraction, addition of the inhibitor decreased the size of the replication products, but this effect was not reversed by the addition of PCNA (Fig.  5, lanes 4-6) . This indicated that one or more additional factors present in the 0.3 M PC fractiont but missing from the immunopurified polymerase a-primase complex preparation, were required for the inhibition to be reversed. This conclusion was verified by further fractionation of the 0.3 M PC fraction on DEAE-Sepharose, which separated the polymerase a-primase complex (eluted at 0.28 M NaCl, the 0.28 M DFAE fraction) from an activator fraction (eluted at 0.08 M NaCl). The activator fraction was further chromatographed on hydroxylapatite and eluted at a concentration of 0.5 M potassium phosphate. This fraction (0.5 M HAP), when combined with the inhibitor fraction and immunopurified polymerase a-primase complex, yielded small DNA products that were elongated in the presence of PCNA (Fig. 5,  lanes 7 and 8) . Similar results were obtained with the 0.2# M DEAE DNA polymerase a-primase complex that was isolated by further fractionation of the 0.3 M PC fractiqp ( 5, lanes [13] [14] [15] [16] [17] . In these experiments the effect of the inhibitor was not quantitatively reversed by the addition of the 0.5 M HAP fraction, due to a low recovery of the activator activity. In all reactions carried out with the inhibitor and activating fractions, the addition of aphidicolin completely prevented DNA synthesis, as did the omission of SV40 T antigen.
Further purification of the inhibitor by glycerol gradient centrifugation (see Materials and Methods) also resolved it from an activating factor that was required for the PCNAmediated elongation reaction. The activation factor isolated from the 0.3 M PC fraction and the activator isolated from the inhibitor fraction appear to be different. Thus, the elongation phase of DNA synthesis that is carried out by the four purified proteins (SV40 T antigen, HeLa At present, the requirements for the elongation of primed templates in eukaryotic systems are unclear. DNA polymerase a was assumed to be the only polymerase involved in replication. Recently, DNA polymerase 8 has been proposed as an entity distinct from DNA polymerase a that is also involved in replication. These two polymerases were reported to differ immunologically and in some of their intrinsic properties (29) (30) (31) . Further, some preparations of DNA polymerases 8 have been shown to require PCNA for elongation activity (29) . Nevertheless, some of the characteristics used to distinguish polymerase a from polymerase 8 have been questioned, making the distinction between these enzymes less clear. For example, the presence of a 3' --5' exonuclease and the resistance of chain elongation to the inhibitor N2-[p-(n-butyl)phenyl]-dGTP, properties thought to be specific for DNA polymerase 8, have also been observed with the 180-kDa catalytic subunit of DNA polymerase a isolated from Drosophila (32, 33) . In contrast, the intact DNA polymerase a-primase complex of Drosophila did not contain 3' -* 5' exonuclease activity and it was inhibited by low concentrations of N2-[p-(n-butyl)phenyl]-dGTP (28, 29) . Further studies will be required to elucidate the differences between these two DNA polymerases and their roles in replication.
A number of studies have suggested an important role for PCNA in replication and in the control of cellular proliferation (17, 20, 21, 34 
